6-Year follow-up of 522 HIV-positive individuals screened for Mycobacterium tuberculosis infection in Denmark

European Respiratory Journal

Volumn 44, Issue 2, 2014, Pages 540-543

  Soborg, Christian ^a   Ruhwald, Morten ^a,b   Andersen, Peter H ^b   Ravn, Pernille ^c  

^a Mental Health Center Glostrup   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; GAMMA INTERFERON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COHORT ANALYSIS; DENMARK; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS TEST KIT; OUTPATIENT DEPARTMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCREENING; TUBERCULOSIS; COMPLICATION; DIAGNOSTIC TEST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INCIDENCE; INFECTION CONTROL; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY;

COHORT STUDIES; COMMUNICABLE DISEASE CONTROL; DENMARK; DIAGNOSTIC TESTS, ROUTINE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; INTERFERON-GAMMA; ISONIAZID; MALE; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TUBERCULOSIS;

EID: 84905649607     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00170913     Document Type: Article

References (13)

1. EPI-NEWS. Tuberculosis 2011, Part I. No. 50, 2012. www.ssi.dk/English/ News/EPI-NEWS/2012/No%2050%20-%202012.aspx Date last updated: December 12, 2012. Date last accessed: January 3, 2014.
2. Taarnhoj GA, Engsig FN, Ravn P, et al. Incidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007. BMC Pulm Med 2011; 11: 26.
3. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350: 2060-2067.
4. Lawn SD, Bekker LG, Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS 2005; 19: 1113-1124. (Pubitemid 41059253)
5. Pontali E, Pasticci MB, Matteelli A, et al. Tuberculosis and HIV co-infection: do we have a surveillance system in Europe? Eur Respir J 2011; 38: 1258-1260.
6. Podlekareva DN, Panteleev AM, Grint D, et al. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe. Eur Respir J 2014; 43: 166-177.
7. Elzi L, Schlegel M, Weber R, et al. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007; 44: 94-102. (Pubitemid 44968992)
8. Whalen CC, Johnson JL, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med 1997; 337: 801-808. (Pubitemid 27391629)
9. Durovni B, Saraceni V, Moulton LH, et al. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis 2013; 13: 852-858.
10. World Health Organisation. WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stake holders. Geneva, WHO, 2012.
11. Brock I, Ruhwald M, Lundgren B, et al. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 2006; 7: 56.
12. The Danish HIV Cohort Study. www.rigshospitalet.dk/RHenglish/Menu/ Departments+and+Clinics/Finsen+Centre/Department+of+Infectious+Diseases-old/ Research/ Date last updated: November 13, 2013. Date last accessed: January 3, 2014.
13. Aichelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a wholeblood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009; 48: 954-962.